A novel immunostimulatory TLR7/8 agonist is curative as a monotherapy in Lewis Lung Carcinoma and synergizes with anti-PD-1 in B16F10 and MC38 tumor models
Intranasal administration of a novel synthetic TLR4 agonist suppresses allergen-specific Th2 responses in mice
